NTELAQ Trademark

Trademark Overview


On Thursday, October 27, 2011, a trademark application was filed for NTELAQ with the United States Patent and Trademark Office. The USPTO has given the NTELAQ trademark a serial number of 85457572. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 11, 2016. This trademark is owned by Novartis AG. The NTELAQ trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment and prevention of disorders of the metabolic system, the musculo-skeletal system, the genitourinary system and for the treatment of inflammatory disorders; pharmaceutical preparations for use in oncology and hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of gastroenterological disorders; Pharmaceutical products for ophthalmological use; Pharma...
ntelaq

General Information


Serial Number85457572
Word MarkNTELAQ
Filing DateThursday, October 27, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 11, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 16, 2012

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment and prevention of disorders of the metabolic system, the musculo-skeletal system, the genitourinary system and for the treatment of inflammatory disorders; pharmaceutical preparations for use in oncology and hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of gastroenterological disorders; Pharmaceutical products for ophthalmological use; Pharmaceutical products for treating respiratory diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 31, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, January 11, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 11, 2016ABANDONMENT - NO USE STATEMENT FILED
Friday, June 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 4, 2015EXTENSION 5 GRANTED
Sunday, May 31, 2015EXTENSION 5 FILED
Sunday, May 31, 2015TEAS EXTENSION RECEIVED
Wednesday, December 17, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 16, 2014EXTENSION 4 GRANTED
Wednesday, December 10, 2014EXTENSION 4 FILED
Wednesday, December 10, 2014TEAS EXTENSION RECEIVED
Saturday, June 14, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 13, 2014EXTENSION 3 GRANTED
Tuesday, June 10, 2014EXTENSION 3 FILED
Tuesday, June 10, 2014TEAS EXTENSION RECEIVED
Tuesday, January 28, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 27, 2014EXTENSION 2 GRANTED
Friday, December 6, 2013EXTENSION 2 FILED
Friday, January 24, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 6, 2013TEAS EXTENSION RECEIVED
Tuesday, June 11, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 8, 2013EXTENSION 1 GRANTED
Saturday, June 8, 2013EXTENSION 1 FILED
Saturday, June 8, 2013TEAS EXTENSION RECEIVED
Tuesday, December 11, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 16, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 16, 2012PUBLISHED FOR OPPOSITION
Wednesday, September 26, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 11, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 7, 2012ASSIGNED TO LIE
Tuesday, August 28, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 6, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 6, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 6, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 7, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 7, 2012NON-FINAL ACTION E-MAILED
Tuesday, February 7, 2012NON-FINAL ACTION WRITTEN
Tuesday, January 31, 2012ASSIGNED TO EXAMINER
Monday, October 31, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 31, 2011NEW APPLICATION ENTERED IN TRAM